Premier PE Ratio 2012-2025 | PINC
Current and historical p/e ratio for Premier (PINC) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Premier PE ratio as of November 11, 2025 is 22.54.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Premier PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-11 | 28.17 | 0.00 | |
| 2025-09-30 | 27.80 | $-0.48 | 0.00 |
| 2025-06-30 | 21.75 | $0.22 | 98.89 |
| 2025-03-31 | 18.95 | $0.57 | 33.25 |
| 2024-12-31 | 20.60 | $-0.10 | 0.00 |
| 2024-09-30 | 19.25 | $1.36 | 14.16 |
| 2024-06-30 | 17.79 | $1.03 | 17.27 |
| 2024-03-31 | 20.82 | $0.64 | 32.53 |
| 2023-12-31 | 20.85 | $1.39 | 15.00 |
| 2023-09-30 | 19.85 | $1.48 | 13.41 |
| 2023-06-30 | 25.29 | $1.47 | 17.20 |
| 2023-03-31 | 29.35 | $1.54 | 19.06 |
| 2022-12-31 | 31.52 | $1.47 | 21.44 |
| 2022-09-30 | 30.39 | $1.55 | 19.60 |
| 2022-06-30 | 31.75 | $2.16 | 14.70 |
| 2022-03-31 | 31.50 | $2.31 | 13.64 |
| 2021-12-31 | 36.24 | $2.38 | 15.23 |
| 2021-09-30 | 33.94 | $2.12 | 16.01 |
| 2021-06-30 | 30.30 | $2.57 | 11.79 |
| 2021-03-31 | 29.32 | $1.86 | 15.76 |
| 2020-12-31 | 30.23 | $2.01 | 15.04 |
| 2020-09-30 | 28.13 | $-5.22 | 0.00 |
| 2020-06-30 | 29.19 | $-6.15 | 0.00 |
| 2020-03-31 | 27.86 | $-10.49 | 0.00 |
| 2019-12-31 | 32.26 | $-10.55 | 0.00 |
| 2019-09-30 | 24.63 | $-2.99 | 0.00 |
| 2019-06-30 | 33.31 | $-16.28 | 0.00 |
| 2019-03-31 | 29.37 | $-17.80 | 0.00 |
| 2018-12-31 | 31.81 | $-20.21 | 0.00 |
| 2018-09-30 | 38.99 | $-18.88 | 0.00 |
| 2018-06-30 | 30.98 | $-3.68 | 0.00 |
| 2018-03-31 | 26.66 | $-3.61 | 0.00 |
| 2017-12-31 | 24.86 | $-3.26 | 0.00 |
| 2017-09-30 | 27.74 | $-4.19 | 0.00 |
| 2017-06-30 | 30.66 | $-6.33 | 0.00 |
| 2017-03-31 | 27.11 | $0.07 | 387.23 |
| 2016-12-31 | 25.85 | $2.08 | 12.43 |
| 2016-09-30 | 27.54 | $-0.32 | 0.00 |
| 2016-06-30 | 27.85 | $-0.34 | 0.00 |
| 2016-03-31 | 28.41 | $-2.88 | 0.00 |
| 2015-12-31 | 30.04 | $-13.35 | 0.00 |
| 2015-09-30 | 29.27 | $-12.97 | 0.00 |
| 2015-06-30 | 32.75 | $-15.79 | 0.00 |
| 2015-03-31 | 32.00 | $1.54 | 20.78 |
| 2014-12-31 | 28.55 | $27.88 | 1.02 |
| 2014-09-30 | 27.98 | $28.85 | 0.97 |
| 2014-06-30 | 24.70 | $31.38 | 0.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.325B | $1.013B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.160B | 27.39 |
| HCA Healthcare (HCA) | United States | $104.809B | 17.35 |
| CVS Health (CVS) | United States | $98.432B | 11.32 |
| Cencora (COR) | United States | $70.698B | 22.81 |
| Elevance Health (ELV) | United States | $67.512B | 9.90 |
| Natera (NTRA) | United States | $28.518B | 0.00 |
| DiDi Global (DIDIY) | China | $26.027B | 21.27 |
| Labcorp Holdings (LH) | United States | $21.648B | 16.51 |
| Medpace Holdings (MEDP) | United States | $16.913B | 41.99 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.316B | 0.00 |
| ICON (ICLR) | Ireland | $12.734B | 12.64 |
| Solventum (SOLV) | United States | $12.452B | 12.09 |
| CochLear (CHEOY) | Australia | $12.172B | 0.00 |
| Viatris (VTRS) | United States | $11.714B | 4.36 |
| Revvity (RVTY) | United States | $10.462B | 19.26 |
| HealthEquity (HQY) | United States | $8.601B | 34.42 |
| Charles River Laboratories (CRL) | United States | $8.316B | 16.02 |
| Avantor (AVTR) | United States | $7.841B | 11.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.997B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.872B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.054B | 36.10 |
| Bausch + Lomb (BLCO) | Canada | $5.656B | 37.14 |
| Sotera Health (SHC) | United States | $4.472B | 21.56 |
| GeneDx Holdings (WGS) | United States | $4.122B | 72.40 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| Alignment Healthcare (ALHC) | United States | $3.278B | 0.00 |
| Concentras Parent (CON) | United States | $2.469B | 15.41 |
| Surgery Partners (SGRY) | United States | $2.056B | 26.73 |
| Progyny (PGNY) | United States | $2.036B | 40.03 |
| Organon (OGN) | United States | $2.004B | 2.11 |
| Establishment Labs Holdings (ESTA) | $1.967B | 0.00 | |
| Ardent Health (ARDT) | United States | $1.955B | 7.55 |
| Pediatrix Medical (MD) | United States | $1.938B | 11.57 |
| PACS (PACS) | United States | $1.905B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.331B | 0.00 |
| Omada Health (OMDA) | $1.196B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.063B | 17.00 |
| CareDx (CDNA) | United States | $0.859B | 14.03 |
| Embecta (EMBC) | United States | $0.799B | 4.68 |
| InnovAge Holding (INNV) | United States | $0.685B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.668B | 9.20 |
| Nutex Health (NUTX) | United States | $0.660B | 10.00 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.551B | 0.00 |
| Pomdoctor - (POM) | China | $0.544B | 0.00 |
| Charming Medical (MCTA) | $0.466B | 0.00 | |
| So-Young (SY) | China | $0.428B | 0.00 |
| CryoPort (CYRX) | United States | $0.428B | 0.00 |
| Enhabit (EHAB) | United States | $0.401B | 18.02 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.385B | 5.78 |
| SBC Medicals (SBC) | United States | $0.355B | 7.77 |
| KindlyMD (NAKA) | United States | $0.325B | 0.00 |
| Oncology Institute (TOI) | United States | $0.310B | 0.00 |
| Agilon Health (AGL) | United States | $0.273B | 0.00 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.175B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.130B | 0.00 |
| DocGo (DCGO) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.096B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.63 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |